The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
for people dying people say well it doesn't happen at all you know why they died the GBM before they start recognizing they have metastatic liver cancer but when you look at livers and kidneys and these other organs from patients who have died from GBM those studies that have looked have found cancer so clearly these sales are coming out of the brain and they're getting into the other organs
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
there aren't that many cancers that can kill you without spreading let's list the ones that can brain cancer can kill you without spreading right so glioblastoma multiforme can kill you and it doesn't leave the brain primary hepatic cancer can kill you without spreading hepatocellular carcinoma can kill you um i suppose lung cancer can kill you without spreading though it's less common
there aren't that many cancers that can kill you without spreading let's list the ones that can brain cancer can kill you without spreading right so gasto multiform can kill you and it doesn't leave the brain primary hepatic cancer can kill you without spreading hepatocellular carcinoma can kill you um I suppose lung cancer can kill you without spreading though it's less common am I missing an example is there some other cancer that can kill you shy of metastasizing I think if you've for all for all intents and purposes yes okay I think you're right okay so that's principle number one
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.